Anthrax Industry report published/ Research and Markets

Wondering which corporations feed at the anthrax biodefense rice bowl?  For a minimum of $995 (US) you can find out about where the anthrax money is being spent and who’s doing what. Yet the biggest feeder (Emergent BioSolutions) is missing from the list. So is Pharmathene, which was perhaps Emergent’s biggest competitor, and which just had its USG contract for anthrax vaccine scaled back today.

The Anthrax Partnering 2007-2012 report provides understanding and access to the anthrax partnering deals and agreements entered into by the worlds leading healthcare companies.”

Top anthrax deals by valueDeals listed by company A-Z, industry sector, stage of development, technology type. 


Companies mentioned: 
Abbott
Actavis
Actelion
Allergan
Amgen
Aspen Pharmacare
Astellas
AstraZeneca
Baxter International
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly
Endo Pharmaceuticals
Forest Laboratories
Galderma
Gilead Sciences
GlaxoSmithKline
Grifols
Hospira
Johnson & Johnson
Kyowa Hakko Kirin
Lundbeck
Menarini
Merck & Co
Merck KGaA
Mitsubishi Tanabe
Novartis
Novo Nordisk
Otsuka
Pfizer
Purdue
Roche
Sanofi
Servier
Shionogi
Shire
Takeda
Teva
Valeant
Warner Chilcott
Watson

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
Scroll to Top